WT
MRNA icon

Washington Trust’s Moderna MRNA Stock Holding History

Washington Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,428
Closed -$225K – 301
2026
Q1 		$225K Buy
+4,428
New +$207K 0.01% 267
2025
Q2 		– Sell
-4,628
Closed -$131K – 538
2025
Q1 		$131K Sell
4,628
-300
-6% -$10.6K 0.01% 293
2024
Q4 		$205K Sell
4,928
-121
-2% -$5.78K 0.01% 262
2024
Q3 		$337K Sell
5,049
-2,512
-33% -$231K 0.01% 236
2024
Q2 		$898K Hold
7,561
– – 0.03% 159
2024
Q1 		$806K Hold
7,561
– – 0.03% 162
2023
Q4 		$752K Hold
7,561
– – 0.03% 166
2023
Q3 		$781K Hold
7,561
– – 0.03% 146
2023
Q2 		$919K Hold
7,561
– – 0.04% 142
2023
Q1 		$1.16M Sell
7,561
-22
-0.3% -$3.63K 0.05% 132
2022
Q4 		$1.36M Hold
7,583
– – 0.06% 125
2022
Q3 		$897K Buy
7,583
+121
+2% +$18.4K 0.05% 136
2022
Q2 		$1.07M Hold
7,462
– – 0.05% 129
2022
Q1 		$1.28M Hold
7,462
– – 0.05% 129
2021
Q4 		$1.9M Sell
7,462
-788
-10% -$230K 0.07% 118
2021
Q3 		$3.17M Sell
8,250
-721
-8% -$266K 0.09% 137
2021
Q2 		$2.11M Buy
8,971
+312
+4% +$55.8K 0.06% 150
2021
Q1 		$1.13M Hold
8,659
– – 0.03% 169
2020
Q4 		$905K Buy
8,659
+8,624
+24,640% +$872K 0.03% 177
2020
Q3 		$2K Buy
+35
New +$2.44K ﹤0.01% 880

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Washington Trust's MRNA Position: Q2 2026 in Review

Washington Trust sold out of Moderna (MRNA) in Q2 2026, closing a stake of 4,428 shares — an estimated $225K sold.

Washington Trust first reported a position in MRNA in Q3 2020 and held it in 20 quarters. The position peaked at $3.17M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Washington Trust reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Washington Trust sold 4,428 Moderna shares in Q2 2026, an estimated $225K.
  • Washington Trust first reported a position in Moderna in Q3 2020 and held it in 20 quarters.
  • Washington Trust's Moderna position peaked at $3.17M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Washington Trust's 13F filing for Q2 2026, filed 3 Aug 2026.